ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Sarcopenia and Testosterone Deficiency with Chronic Liver Disease; Post-Liver Transplant Utility of Short Term Testosterone Replacement Therapy

A. Jain1, D. Haussner2

1Penn State Health Milton S. Hershey Medical Center, Hershey, PA, 2Presbyterian, New York, NY

Meeting: 2022 American Transplant Congress

Abstract number: 1427

Keywords: Liver, Morbidity, Risk factors, Survival

Topic: Clinical Science » Liver » 53 - Liver: Cirrhosis - Portal Hypertension and Other Complications

Session Information

Session Name: Liver: Cirrhosis - Portal Hypertension and Other Complications

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Chronic liver disease is often associated with testosterone deficiency. However, testosterone therapy does not improve survival. So far, after a successful liver transplant (LTx), testosterone replacement therapy for functional sarcopenia is not studied. Purpose: 1) Define post-LTx functional sarcopenia with serum testosterone level. 2) Examine the role of short-term testosterone replacement therapy with the active in-bed exercise of upper and lower extremity joints. 3) Correlate functional sarcopenia with skeletal muscle index (SMI) and skeletal muscle density (SMD) in relation to ascites, pleural effusion subtracted (APES) body mass index (BMI).

*Methods: Sixteen post-LTx recipients received testosterone replacement therapy with functional sarcopenia, defined as 1) inability to get out of bed and stand with help of two physiotherapists, within 24 hours post-extubation, and/or ventilatory dependency >2 days post-LTx with allograft and without major complications. Pre- and post-operative demographics, laboratory, and radiological data were retrieved; BMI, SMI, and SMD were calculated. (Figure 2)

*Results: The mean testosterone level was 28.3 ng/dL. 12 patients received one dose and the remaining four received >1 dose of testosterone cypionate 200mg. Mean hospital stay was 26 days. Seven patients were discharged home and the remaining nine to a rehabilitation facility or nursing home. One patient died from a cardiac event and another from recurrent metastatic malignancy. One- and five-year actuarial patent and graft survival were 93.8% and 87.5%, respectively ( Figure-1A). Overall, five subjects were sarcopenic by SMI, and six subjects had poor muscle quality by SMD. (Figure-1B)

*Conclusions: Post-LTx testosterone deficiency exists with functional sarcopenia. Two-thirds of recipients either have low SMI and/or have low SMD. Short-term testosterone replacement therapy with in-bed active exercise provides five-year patient and graft survival of 87.5%. The dosing, frequency, risk, and benefit of testosterone replacement therapy for LTx recipients with various degrees of functional sarcopenia could be evaluated. studies.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Jain A, Haussner D. Sarcopenia and Testosterone Deficiency with Chronic Liver Disease; Post-Liver Transplant Utility of Short Term Testosterone Replacement Therapy [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/sarcopenia-and-testosterone-deficiency-with-chronic-liver-disease-post-liver-transplant-utility-of-short-term-testosterone-replacement-therapy/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences